Status:
COMPLETED
Validation of a Novel Screening Test for Maternal Insulin Resistance
Lead Sponsor:
The University of Texas Medical Branch, Galveston
Conditions:
Insulin Resistance, Diabetes
Eligibility:
FEMALE
18-50 years
Brief Summary
This will be a validation study of Quantose IR and Quantose IGT to predict insulin resistance and identify patients with prediabetes. This is a pilot study of 100 subjects. Based on the results of thi...
Detailed Description
This is a prospective cohort non-interventional study. Subjects will be identified during the time of a prenatal visit at one of the UTMB clinics. All necessary institutional and regulatory approval w...
Eligibility Criteria
Inclusion
- 18 years or older.
- Singleton pregnancy.
- Able to provide consent.
- Gestational age 10 0/7 to 13 6/7 weeks.
- Planned delivery at UTMB (John Sealy Hospital (JSH) or League City Hospital Campus.
- Pre-pregnancy or early pregnancy BMI \> or = 30 kg/m2
Exclusion
- \-
Key Trial Info
Start Date :
December 15 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 15 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03388697
Start Date
December 15 2017
End Date
July 15 2019
Last Update
April 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ashley Salazar
Galveston, Texas, United States, 77555